U.S. markets close in 38 minutes

Opiant Pharmaceuticals, Inc. (OPNT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.20-0.07 (-0.57%)
As of 3:17PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/5/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
53.14M34.19M31.85M38.45M40.79M
Enterprise Value 3
23.18M3.49M1.86M6.88M10.58M
Trailing P/E
4.00N/A4.254.094.41
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
1.761.331.051.241.26
Price/Book (mrq)
1.500.960.931.141.19
Enterprise Value/Revenue 3
0.780.350.201.092.47
Enterprise Value/EBITDA 7
N/A-8.452.45-33.03-6.28

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 33.98%
S&P500 52-Week Change 344.65%
52 Week High 314.98
52 Week Low 36.79
50-Day Moving Average 311.21
200-Day Moving Average 310.06

Share Statistics

Avg Vol (3 month) 328.68k
Avg Vol (10 day) 317.79k
Shares Outstanding 54.33M
Implied Shares Outstanding 6N/A
Float 3.85M
% Held by Insiders 17.28%
% Held by Institutions 124.29%
Shares Short (Apr 14, 2021) 419.25k
Short Ratio (Apr 14, 2021) 40.81
Short % of Float (Apr 14, 2021) 40.47%
Short % of Shares Outstanding (Apr 14, 2021) 40.45%
Shares Short (prior month Mar 14, 2021) 412.2k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:100
Last Split Date 3Dec 30, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin -6.28%
Operating Margin (ttm)-7.56%

Management Effectiveness

Return on Assets (ttm)-2.78%
Return on Equity (ttm)-5.32%

Income Statement

Revenue (ttm)29.63M
Revenue Per Share (ttm)6.97
Quarterly Revenue Growth (yoy)29.40%
Gross Profit (ttm)14.19M
EBITDA -2.12M
Net Income Avi to Common (ttm)-1.86M
Diluted EPS (ttm)-0.44
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)48.25M
Total Cash Per Share (mrq)11.24
Total Debt (mrq)18.98M
Total Debt/Equity (mrq)53.49
Current Ratio (mrq)9.20
Book Value Per Share (mrq)8.34

Cash Flow Statement

Operating Cash Flow (ttm)-2.03M
Levered Free Cash Flow (ttm)-157.65k